Loading...
The Chemours Company
CC•NYSE
Basic Materials
Chemicals - Specialty
$13.89
$-0.10(-0.71%)
The Chemours Company (CC) Financial Performance & Income Statement Overview
Review The Chemours Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-4.07%
↓ 4.07%
Operating Income Growth
596.74%
↑ 596.74%
Net Income Growth
136.13%
↑ 136.13%
Operating Cash Flow Growth
-213.85%
↓ 213.85%
Operating Margin
7.19%
↑ 7.19%
Gross Margin
19.00%
↑ 19.00%
Net Profit Margin
0.53%
↑ 0.53%
ROE
4.84%
↑ 4.84%
ROIC
7.29%
↑ 7.29%
The Chemours Company (CC) Income Statement & Financial Overview
Review The Chemours Company's (CC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.39B | $1.50B | $1.54B | $1.35B |
| Cost of Revenue | $1.12B | $1.22B | $1.23B | $1.06B |
| Gross Profit | $273.00M | $286.00M | $307.00M | $286.00M |
| Gross Profit Ratio | $0.20 | $0.19 | $0.20 | $0.21 |
| R&D Expenses | $26.00M | $29.00M | $26.00M | $28.00M |
| SG&A Expenses | $169.00M | $135.00M | $139.00M | $142.00M |
| Operating Expenses | $198.00M | $164.00M | $165.00M | $174.00M |
| Total Costs & Expenses | $1.32B | $1.38B | $1.40B | $1.24B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $67.00M | $69.00M | $66.00M | $63.00M |
| Depreciation & Amortization | $78.00M | $78.00M | $74.00M | $71.00M |
| EBITDA | $153.00M | $117.00M | $216.00M | $186.00M |
| EBITDA Ratio | $0.11 | $0.08 | $0.14 | $0.14 |
| Operating Income | $75.00M | $122.00M | $142.00M | $116.00M |
| Operating Income Ratio | $0.05 | $0.08 | $0.09 | $0.09 |
| Other Income/Expenses (Net) | -$66.00M | -$152.00M | -$60.00M | -$49.00M |
| Income Before Tax | $9.00M | -$30.00M | $82.00M | $67.00M |
| Income Before Tax Ratio | $0.006 | -$0.02 | $0.05 | $0.05 |
| Income Tax Expense | $17.00M | -$3.00M | $12.00M | $15.00M |
| Net Income | -$8.00M | -$27.00M | $70.00M | $52.00M |
| Net Income Ratio | -$0.006 | -$0.02 | $0.05 | $0.04 |
| EPS | -$0.05 | -$0.18 | $0.47 | $0.35 |
| Diluted EPS | -$0.05 | -$0.18 | $0.47 | $0.34 |
| Weighted Avg Shares Outstanding | $149.83M | $149.70M | $149.41M | $149.04M |
| Weighted Avg Shares Outstanding (Diluted) | $149.83M | $149.70M | $150.12M | $150.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan